AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CLINUVEL PHARMACEUTICALS LTD

11.850

-0.020-0.17%

Volume:151.69K

Turnover:1.80M

Market Cap:591.87M

PE:15.40

High:11.970

Open:11.750

Low:11.710

Close:11.870

Loading ...

Overview Company News Filings

Clinuvel in Talks with European Regulators Over Dosage Expansion for Metabolic Disorder Drug

MT Newswires Live

BRIEF-Clinuvel Pharmaceuticals Says Decision To Strategically Prioritise Three Key Clinical Programs

Clinuvel Pharmaceuticals to Prioritize Programs with Highest Likelihood of Regulatory Approval, Commercial Success

MT Newswires Live

Clinuvel Pharmaceuticals Ltd - Decision to Strategically Prioritise Three Key Clinical Programs

THOMSON REUTERS

Three High Growth Tech Stocks in Australia

Simply Wall St.

ASX Growth Leaders Featuring Clinuvel Pharmaceuticals And 2 Insider-Favored Stocks

Simply Wall St.

ASX Growth Companies With Significant Insider Ownership October 2024

Simply Wall St.

Top ASX Growth Companies With Insider Ownership October 2024

Simply Wall St.

ASX Growth Stocks With Strong Insider Confidence For October 2024

Simply Wall St.

3 ASX Growth Stocks With Insider Ownership And Up To 32% ROE

Simply Wall St.

ASX Growth Stocks With High Insider Confidence For October 2024

Simply Wall St.

3 ASX Growth Stocks With High Insider Ownership Delivering 32 Percent Return On Equity

Simply Wall St.

Clinuvel Pharmaceuticals Ltd (CLVLF) (Q4 2024) Earnings Call Highlights: Record Revenue and ...

3 ASX Growth Stocks With Insider Ownership Up To 36%

Simply Wall St.

ASX Growth Companies With High Insider Ownership For October 2024

Simply Wall St.

3 ASX Growth Companies Insiders Are Investing In

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CUV.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUV.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","market":"AU","secType":"STK","nameCN":"CLINUVEL PHARMACEUTICALS LTD","latestPrice":11.85,"timestamp":1741583520000,"preClose":11.87,"halted":0,"volume":151690,"delay":0,"changeRate":-0.001685,"change":-0.02,"floatShares":41256001,"shares":49946800,"eps":0.769445,"lyrEps":0.7151,"pbRate":2.72,"amount":1796840,"amplitude":0.021904,"volumeRatio":0.5695142249360717,"dividePrice":0.05,"prevYearClose":12.06,"fiveDayClose":12.23,"twentyDayClose":11.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","floatShares":41256001,"roa":"14.22%","roe":"19.59%","lyrEps":0.7151,"volumeRatio":0.5695142249360717,"shares":49946800,"dividePrice":0.05,"high":11.97,"amplitude":0.021904,"preClose":11.87,"low":11.71,"week52Low":10.89,"pbRate":"2.72","psRate":"6.50","week52High":17.652,"institutionHeld":0,"latestPrice":11.85,"eps":0.769445,"divideRate":0.004219,"volume":151690,"delay":0,"ttmEps":0.769445,"open":11.75,"prevYearClose":12.06,"prevWeekClose":11.87,"prevMonthClose":11.49,"prevQuarterClose":12.06,"fiveDayClose":12.23,"twentyDayClose":11.5,"sixtyDayClose":12.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUV.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-06","defaultRemindTime":1725494400000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-20","payableDate":"2024-09-06","currency":"AUD","dateTimestamp":1725458400000,"payDate":"2024-09-20"},{"date":"2024-08-29","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724889600000,"name":null,"time":"","dateTimestamp":1724853600000,"actualEps":null},{"date":"2024-02-22","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708556400000,"name":null,"time":"","dateTimestamp":1708520400000,"actualEps":null},{"date":"2023-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":"2023-08-29","type":"dividend","market":"AU","newRecordDate":"2023-09-06","defaultRemindTime":1693872000000,"name":"Clinuvel Pharmaceuticals Ltd","recordDate":"2023-09-20","payableDate":"2023-09-06","currency":"AUD","dateTimestamp":1693836000000,"payDate":"2023-09-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.04,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.05,"currency":"AUD"},{"executeDate":"2024-09-05","recordDate":"2024-09-06","paymentDate":"2024-09-20","value":0.05,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CUV.AU\",pageSize:16,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2484618080","title":"Clinuvel in Talks with European Regulators Over Dosage Expansion for Metabolic Disorder Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2484618080","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484618080?lang=en_us&edition=fundamental","pubTime":"2024-11-20 09:52","pubTimestamp":1732067538,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals  said it is in talks with the European Medicines Agency  to increase the recommended maximum dose of its drug Scenesse for adult patients with erythropoietic protoporphyria , according to a Wednesday filing with the Australian bourse.EPP is an inherited condition characterized by extreme photosensitivity and could lead to liver disease.The EMA's Pharmacovigilance Risk Assessment Committee will decide whether to maintain the existing drug label or expand it to up to six times per year, the filing said.The outcome is expected by the first quarter of 2025, according to the filing.Clinuvel Pharmaceuticals' shares were down more than 2% in recent Wednesday trade.Price : $13.30, Change: $-0.32, Percent Change: -2.39%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0426412945.USD","LU0994945656.USD","EPP","LU2238339852.HKD","BK7067","AUD","BK4582","CUV.AU","LU0426417589.USD","BK7508","LU0345774631.USD","LU1043141123.HKD","BK4125"],"gpt_icon":0},{"id":"2484666409","title":"BRIEF-Clinuvel Pharmaceuticals Says Decision To Strategically Prioritise Three Key Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2484666409","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484666409?lang=en_us&edition=fundamental","pubTime":"2024-11-18 09:09","pubTimestamp":1731892159,"startTime":"0","endTime":"0","summary":"BRIEF-Clinuvel Pharmaceuticals Says Decision To Strategically Prioritise Three Key Clinical ProgramsNov 18 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX:DECISION TO STRATEGICALLY PRIORITISE THREE KE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nFWN3MN0C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUV.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2484668044","title":"Clinuvel Pharmaceuticals to Prioritize Programs with Highest Likelihood of Regulatory Approval, Commercial Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2484668044","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484668044?lang=en_us&edition=fundamental","pubTime":"2024-11-18 08:04","pubTimestamp":1731888243,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals (ASX:CUV) refocused resources to prioritize its three key areas of clinical development: vitiligo, adrenocorticotropic hormone, and porphyrias, according to a Monday filing wi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AUD","LU0426417589.USD","LU0994945656.USD","LU2238339852.HKD","BK7067","BK7508","CUV.AU","LU0426412945.USD","BK4125","LU0345774631.USD","LU1043141123.HKD"],"gpt_icon":0},{"id":"2484865486","title":"Clinuvel Pharmaceuticals Ltd - Decision to Strategically Prioritise Three Key Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2484865486","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484865486?lang=en_us&edition=fundamental","pubTime":"2024-11-18 05:46","pubTimestamp":1731880013,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241117:nFWN3MN0C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CUV.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2481505619","title":"Three High Growth Tech Stocks in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2481505619","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481505619?lang=en_us&edition=fundamental","pubTime":"2024-11-06 12:06","pubTimestamp":1730865978,"startTime":"0","endTime":"0","summary":"As the Australian market experiences a modest uptick with the ASX200 rising around 1% to 8,210 points, investors are closely monitoring the ongoing US election and its potential impact on global markets. In this environment of cautious optimism, identifying high growth tech stocks requires careful consideration of factors such as innovation potential, market positioning, and adaptability in dynamic sectors like technology.Click here to see the full list of 61 stocks from our ASX High Growth Tech and AI Stocks screener.Overview: Clinuvel Pharmaceuticals Limited is a biopharmaceutical company that develops and commercializes treatments for genetic, metabolic, systemic, and life-threatening disorders across Australia, Europe, the United States, Switzerland, and internationally with a market cap of A$685.77 million.Operations: Clinuvel Pharmaceuticals generates revenue primarily from its biopharmaceutical sector, amounting to A$88.18 million. The company focuses on developing and commercia","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/three-high-growth-tech-stocks-040618193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4582","BK7501","BK7508","MSB.AU","FCL.AU","BK7067","XAO.AU","XKO.AU","BK7016","XJO.AU","CUV.AU","MESO","EPP"],"gpt_icon":1},{"id":"2478141369","title":"ASX Growth Leaders Featuring Clinuvel Pharmaceuticals And 2 Insider-Favored Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2478141369","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478141369?lang=en_us&edition=fundamental","pubTime":"2024-10-28 11:35","pubTimestamp":1730086500,"startTime":"0","endTime":"0","summary":"As the Australian market holds steady with investors eyeing key inflation data and recent movements in major indices, the focus turns to growth companies showing resilience amidst economic fluctuations. In this environment, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations.Top 10 Growth Companies With High Insider Ownership In Australia. Let's review some notable picks from our screened stocks.Operations: The company generates revenue primarily from its Biopharmaceutical Sector, amounting to A$88.18 million.Get an in-depth perspective on Clinuvel Pharmaceuticals' performance by reading our analyst estimates report here.Insights from our recent valuation report point to the potential undervaluation of Clinuvel Pharmaceuticals shares in the market.Overview: Develop Global Limited, with a market cap of A$662.18 million, is involved in the exploration and development of mineral resource properti","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/hHa1.rnFIozE8uk1FxFmIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7a92075e7c274cfc915511d1e9d413e3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/hHa1.rnFIozE8uk1FxFmIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7a92075e7c274cfc915511d1e9d413e3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-growth-leaders-featuring-clinuvel-033500038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7158","BK7083","BK7116","AV1.AU","BK7016","BK7084","CUV.AU","3DP.AU","BK7508","BK7104","DVP.AU","BK7043","LOT.AU","XAO.AU","GEN.AU","AVA.AU","CYL.AU","XKO.AU","BK7095","BK7067","BK7096","HGO.AU","ACR.AU","BK7129","IPX.AU","XJO.AU","PLT.AU","BK7093","FND.AU"],"gpt_icon":0},{"id":"2478662883","title":"ASX Growth Companies With Significant Insider Ownership October 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2478662883","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478662883?lang=en_us&edition=fundamental","pubTime":"2024-10-25 11:34","pubTimestamp":1729827299,"startTime":"0","endTime":"0","summary":"The Australian market has shown resilience, with the ASX200 rising 0.34% to 8,234 points, driven by gains in big banks and miners, while IT leads as the best performing sector. In this environment of positive momentum and sectoral shifts, growth companies with significant insider ownership can offer unique insights into potential long-term value creation.Top 10 Growth Companies With High Insider Ownership In Australia. Chrysos Corporation is experiencing robust growth, with revenue forecast to increase by 28.3% annually, outpacing the Australian market's 5.5%. Despite recent shareholder dilution and a low projected return on equity of 6.2%, the company plans to achieve profitability within three years, surpassing average market growth expectations. Chrysos reaffirmed its fiscal year 2025 revenue guidance of A$60 million to A$70 million, following a significant sales increase from A$26.82 million to A$45.36 million in the past year.Duratec shows potential with its earnings projected to ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kpZnHWmVXh9fa.5MJ5otJg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/e18325c660d04f2fe88569956b7babe1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kpZnHWmVXh9fa.5MJ5otJg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/e18325c660d04f2fe88569956b7babe1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-growth-companies-significant-insider-033459490.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["HGO.AU","GYG.AU","BK7508","BK7095","BK7137","AVA.AU","BK7043","3DP.AU","CYL.AU","AV1.AU","BK7084","BK7093","FND.AU","BK7050","C79.AU","BK7064","BK7067","XKO.AU","XJO.AU","BK7055","BK7129","BK7104","ACR.AU","GEN.AU","BK7016","DUR.AU","BK7158","CUV.AU","PLT.AU","XAO.AU","BK7096"],"gpt_icon":0},{"id":"2477878090","title":"Top ASX Growth Companies With Insider Ownership October 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2477878090","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477878090?lang=en_us&edition=fundamental","pubTime":"2024-10-22 11:34","pubTimestamp":1729568099,"startTime":"0","endTime":"0","summary":"As the Australian market experiences a downturn with the ASX200 down 1.3% at 8,235 points and all sectors retreating, investors are closely monitoring economic indicators and adjusting their strategies amid shifting rate cut expectations. In such a volatile environment, growth companies with high insider ownership can offer a unique perspective on potential resilience and commitment from those who know the business best.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 97 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Overview: Emerald Resources NL is involved in the exploration and development of mineral reserves in Cambodia and Australia, with a market cap of A$2.90 billion.Operations: The company's revenue primarily comes from mine operations, amounting to A$366.04 million.Emerald Resources is set for significant growth with earnings forecasted to rise by 32.2% annually, surpassing the Australian mar","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UrHBsIrR8XWjKtdqSp2vkw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b3b5a2748dbe57dca97087f8af8726d5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UrHBsIrR8XWjKtdqSp2vkw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b3b5a2748dbe57dca97087f8af8726d5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-asx-growth-companies-insider-033459091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7016","HGO.AU","BK7033","3DP.AU","BK7096","BK7093","BK7084","EMR.AU","BK7508","XAO.AU","CYL.AU","BK7129","GYG.AU","XJO.AU","AVA.AU","BK7158","BK7104","BK7137","PLT.AU","BK7067","BK7095","AV1.AU","CUV.AU","GEN.AU","CCA.AU","XKO.AU","ACR.AU"],"gpt_icon":0},{"id":"2477099601","title":"ASX Growth Stocks With Strong Insider Confidence For October 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2477099601","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477099601?lang=en_us&edition=fundamental","pubTime":"2024-10-21 03:02","pubTimestamp":1729450954,"startTime":"0","endTime":"0","summary":"The Australian market has recently faced a downturn, with the ASX200 closing down 0.87% at 8283 points amid concerns about the Chinese economy's strength, leading to all sectors finishing in the red. In such uncertain times, growth companies with high insider ownership can signal confidence from those closest to the business, suggesting they may be well-positioned to navigate challenging market conditions and capitalize on future opportunities.Top 10 Growth Companies With High Insider Ownership In Australia. Capricorn Metals is experiencing strong growth, with earnings forecasted to rise significantly at 20.5% annually, outpacing the Australian market. The company's recent financial results show a substantial increase in net income to A$87.14 million from A$4.4 million the previous year, reflecting robust operational performance. Insider ownership remains high, which can align management's interests with shareholders'. Capricorn is also expanding its Karlawinda Gold Project, potentiall","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/hHa1.rnFIozE8uk1FxFmIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7a92075e7c274cfc915511d1e9d413e3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/hHa1.rnFIozE8uk1FxFmIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7a92075e7c274cfc915511d1e9d413e3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-growth-stocks-strong-insider-190234112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["PNI.AU","EMR.AU","AV1.AU","BK7016","BK7084","CUV.AU","3DP.AU","BK7508","BK7104","XAO.AU","BK7062","GEN.AU","AVA.AU","CYL.AU","XKO.AU","BK7095","BK7067","BK7096","HGO.AU","ACR.AU","BK7129","XJO.AU","PLT.AU","BK7093","CMM.AU"],"gpt_icon":0},{"id":"2476789438","title":"3 ASX Growth Stocks With Insider Ownership And Up To 32% ROE","url":"https://stock-news.laohu8.com/highlight/detail?id=2476789438","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476789438?lang=en_us&edition=fundamental","pubTime":"2024-10-18 03:05","pubTimestamp":1729191942,"startTime":"0","endTime":"0","summary":"The Australian market has shown positive momentum, climbing 1.1% in the last week and achieving a 17% increase over the past year, with earnings projected to grow by 12% annually. In this environment, stocks that combine strong growth potential with significant insider ownership can be particularly attractive, as they often indicate confidence from those closest to the company's operations.Top 10 Growth Companies With High Insider Ownership In Australia. Overview: Capricorn Metals Ltd is an Australian company focused on the evaluation, exploration, development, and production of gold properties, with a market cap of A$2.43 billion.Overview: Cettire Limited operates as an online luxury goods retailer in Australia, the United States, and internationally, with a market cap of A$850.16 million.Cettire demonstrates strong growth prospects, with earnings expected to increase significantly at 29% annually, surpassing the Australian market. Despite a volatile share price recently, insider conf","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/hHa1.rnFIozE8uk1FxFmIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7a92075e7c274cfc915511d1e9d413e3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/hHa1.rnFIozE8uk1FxFmIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7a92075e7c274cfc915511d1e9d413e3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-growth-stocks-insider-190542755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7021","CMM.AU","XAO.AU","LTR.AU","CYL.AU","XJO.AU","CTT.AU","EMR.AU","PLT.AU","ACR.AU","BK7084","BK7067","BK7508","BK7129","BK7016","AVA.AU","HGO.AU","ROE","3DP.AU","BK7095","XKO.AU","BK7104","AV1.AU","BK7049","BK7093","CUV.AU","BK7096","GEN.AU","BK7504"],"gpt_icon":0},{"id":"2475672079","title":"ASX Growth Stocks With High Insider Confidence For October 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2475672079","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475672079?lang=en_us&edition=fundamental","pubTime":"2024-10-16 11:35","pubTimestamp":1729049705,"startTime":"0","endTime":"0","summary":"As the Australian market faces a potential dip with ASX200 futures indicating a reversal of recent gains, investors are closely watching global influences such as tempered expectations for AI demand and fluctuating commodity prices. In this environment, growth companies with high insider ownership can signal strong internal confidence and may offer appealing prospects for those looking to navigate these uncertain times.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 98 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Operations: The company generates revenue primarily from its Funds Management Operations, amounting to A$48.99 million.Pinnacle Investment Management Group has shown solid financial performance, with earnings rising to A$90.35 million from A$76.47 million year-on-year and revenue increasing to A$48.99 million. The company forecasts a 13.6% annual revenue growth, outpacing the Australian mar","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UrHBsIrR8XWjKtdqSp2vkw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b3b5a2748dbe57dca97087f8af8726d5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UrHBsIrR8XWjKtdqSp2vkw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b3b5a2748dbe57dca97087f8af8726d5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-growth-stocks-high-insider-033505882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LTR.AU","XJO.AU","BK7062","BK7104","BK7016","BK7129","CUV.AU","3DP.AU","EMR.AU","XAO.AU","PLT.AU","XKO.AU","BK7508","AV1.AU","HGO.AU","BK7096","ACR.AU","BK7084","BK7067","AVA.AU","BK7093","GEN.AU","PNI.AU","BK7504","BK7095","CYL.AU","BK7503","TNE.AU"],"gpt_icon":0},{"id":"2475824841","title":"3 ASX Growth Stocks With High Insider Ownership Delivering 32 Percent Return On Equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2475824841","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475824841?lang=en_us&edition=fundamental","pubTime":"2024-10-14 03:01","pubTimestamp":1728846088,"startTime":"0","endTime":"0","summary":"As the ASX200 experiences a slight dip amidst a flat trading day and investors pivot towards gold in response to global economic concerns, the Australian market remains watchful of potential shifts in commodity demands, particularly from China. In this environment of volatility and sector-specific movements, identifying growth companies with high insider ownership can be crucial as these stocks often reflect strong internal confidence and have historically demonstrated resilience and robust returns on equity.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 99 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Cettire demonstrates strong growth potential with insider ownership trends supporting confidence in its future. The company forecasts revenue growth of 16.1% annually, outpacing the broader Australian market, and expects earnings to grow significantly at 29% per year. Recent executive changes, includi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/hHa1.rnFIozE8uk1FxFmIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7a92075e7c274cfc915511d1e9d413e3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/hHa1.rnFIozE8uk1FxFmIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7a92075e7c274cfc915511d1e9d413e3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-growth-stocks-high-190128854.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4215","CTT.AU","BK7096","BK7508","BK7049","BK7095","BK7021","BK7129","BK7093","EQR","AVA.AU","BK4588","AV1.AU","BK7084","HGO.AU","CYL.AU","CUV.AU","3DP.AU","PNI.AU","XAO.AU","BK7067","BK7104","ACR.AU","XKO.AU","GEN.AU","PLT.AU","LTR.AU","XJO.AU","BK7504","BK4585","BK7062","BK7016"],"gpt_icon":0},{"id":"2474778118","title":"Clinuvel Pharmaceuticals Ltd (CLVLF) (Q4 2024) Earnings Call Highlights: Record Revenue and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2474778118","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474778118?lang=en_us&edition=fundamental","pubTime":"2024-10-10 06:42","pubTimestamp":1728513754,"startTime":"0","endTime":"0","summary":"Net Profit Before Tax: Up 11% to $50 million.Dividend: Seventh consecutive annual dividend, third consecutive fully franked dividend.GuruFocus has detected 2 Warning Signs with CLVLF.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Clinuvel Pharmaceuticals Ltd  reported a 15% increase in total revenues and an 11% rise in net profit before tax, marking the largest revenue and profit figures in the company's history.Clinuvel Pharmaceuticals Ltd  declared a seventh consecutive annual dividend, with the third consecutive fully franked dividend.The company has a strong balance sheet with total assets up 19% to $231 million and remains debt-free for the past 19 years.Expenses grew by 19%, driven by increased staff numbers and marketing efforts, which could impact profitability if not managed carefully.The recruitment period for the CUV105 trial has been extended to June 2025, potentially delaying the path to market for new treatments.A: Pete","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/clinuvel-pharmaceuticals-ltd-clvlf-q4-224234566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["CLVLF","CUV.AU"],"gpt_icon":0},{"id":"2474425078","title":"3 ASX Growth Stocks With Insider Ownership Up To 36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474425078","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474425078?lang=en_us&edition=fundamental","pubTime":"2024-10-09 11:35","pubTimestamp":1728444905,"startTime":"0","endTime":"0","summary":"As the ASX200 inches up by 0.05% to 8,180 points amidst a mixed performance across sectors, with telecommunications and IT leading gains while energy and materials lag due to falling iron ore prices, investors are keenly observing the broader market dynamics influenced by global trends such as Wall Street's tech-driven rally. In this environment, growth companies with substantial insider ownership can be particularly appealing as they often signal confidence from those closest to the business, potentially offering resilience and alignment of interests in fluctuating market conditions.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 99 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Humm Group is positioned for growth with expected annual earnings growth of 23.9%, outpacing the Australian market's 12.2%. While revenue is set to increase at 13.1% annually, it remains below the high-growth threshold of 20%","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/00OqBzbQM9NM6aQKBzc4vA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/992331fc596d921e34ccfa3b8813259a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/00OqBzbQM9NM6aQKBzc4vA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/992331fc596d921e34ccfa3b8813259a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-growth-stocks-insider-033505721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MESO","ACR.AU","BK7508","BK7500","AVA.AU","3DP.AU","BK7095","AV1.AU","KGN.AU","CYL.AU","PLT.AU","BK7501","HGO.AU","BK7093","BK7067","BK7084","BK7049","BK7096","XAO.AU","BK7104","BK7129","GEN.AU","MSB.AU","CUV.AU","HUM.AU","BK7153","XKO.AU","XJO.AU","BK7504","LTR.AU","BK7016"],"gpt_icon":0},{"id":"2473606744","title":"ASX Growth Companies With High Insider Ownership For October 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2473606744","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473606744?lang=en_us&edition=fundamental","pubTime":"2024-10-08 11:34","pubTimestamp":1728358498,"startTime":"0","endTime":"0","summary":"As the Australian market navigates a period of mixed performance, with the ASX200 showing slight declines and sectors like Real Estate outperforming others, investors are closely watching commodity prices driven by bullish expectations around Chinese stimulus. In this context, growth companies with high insider ownership can be particularly appealing as they may offer aligned interests between management and shareholders, potentially providing resilience amidst fluctuating market conditions.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 99 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Operations: The company's revenue segments include A$75.08 million from Tasmania and A$243.77 million from Western Australia.Overview: Mineral Resources Limited operates as a mining services company with operations in Australia, Asia, and internationally, and has a market cap of A$10.40 billion.Operations: The company'","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/8ou9h1aPnDmM7LIetWUw9Q--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/3eb1acfa01a97be66f224c62f2ff60fd","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/8ou9h1aPnDmM7LIetWUw9Q--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/3eb1acfa01a97be66f224c62f2ff60fd"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-growth-companies-high-insider-033458664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["3DP.AU","BK7067","BK7016","XKO.AU","XAO.AU","BK7129","BK7508","AVA.AU","CUV.AU","BK7093","MESO","BK7104","BK7084","ACR.AU","BK7501","BK7096","HGO.AU","BK7507","BK7504","PLT.AU","CYL.AU","MSB.AU","GEN.AU","LTR.AU","XJO.AU","MIN.AU","AV1.AU","BK7095"],"gpt_icon":0},{"id":"2473196229","title":"3 ASX Growth Companies Insiders Are Investing In","url":"https://stock-news.laohu8.com/highlight/detail?id=2473196229","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473196229?lang=en_us&edition=fundamental","pubTime":"2024-10-07 03:01","pubTimestamp":1728241302,"startTime":"0","endTime":"0","summary":"Amidst the backdrop of a declining ASX200, which recently closed 0.67% lower at 8,150 points due to investor concerns over Middle Eastern conflicts, certain sectors like Energy have emerged as strong performers. In such volatile market conditions, growth companies with high insider ownership can be particularly appealing as they may indicate confidence from those who know the business best.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 98 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Overview: Cromwell Property Group  is a real estate investor and fund manager operating across three continents with a market capitalization of A$1.18 billion.Operations: The company's revenue segment includes the development of a cell technology platform for commercialization, generating $5.90 million.Mesoblast, with strong insider ownership and minimal recent insider selling, is positioned for significant growth. The ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-growth-companies-insiders-190142780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["ACR.AU","BK7501","BK7096","XAO.AU","BK7504","CMW.AU","XJO.AU","BK7016","GEN.AU","CUV.AU","CYL.AU","QAL.AU","LTR.AU","MSB.AU","BK7067","AVA.AU","MESO","XKO.AU","BK7121","3DP.AU","BK7062","BK7129","AV1.AU","BK7104","BK7154","HGO.AU","BK7093","PLT.AU","BK7508","BK7122","BK7095","BK7084"],"gpt_icon":0}],"pageSize":16,"totalPage":5,"pageCount":3,"totalSize":66}]}}